Founded with the mission to democratize access to clinical-grade Polygenic Risk Scores, Allelica is a software and research company dedicated to advancing clinical genomics. The company provides comprehensive solutions for the development and commercialization of clinical genetic tests, targeting both the healthcare and pharmaceutical industries. Allelica specializes in genetic risk prediction and offers a quality management system designed to develop and implement new genetics-based assays.
Allelica has attracted notable investors and experts in the field of genomics, contributing to its rapid growth and innovation. The company has achieved significant milestones in making advanced genetic testing more accessible and reliable. Its impact is evident in the enhanced capabilities of healthcare providers to predict and manage genetic risks, ultimately improving patient outcomes on a global scale.
